Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06524180

Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension

Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension (TEACH)? a Randomised Controlled Trial and Cost-minimization Analysis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
364 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate whether patients assigned to the telemedicine (HealthCap) group demonstrate non-inferior blood pressure (BP) control compared to patients in the usual care group at 12 months. The main question it aims to answer is: * Do participants in telemedicine group have non-inferior daytime ambulatory blood pressure readings at 12-month, compared to usual care group? * Do participants in telemedicine group have better HT treatment, higher self-efficacy, reduced number of visits to primary care clinics and similar health care utilisation other than GOPCs, compared to usual care group? Participant in telemedicine group will: * Receive reminders to measure 7-day home blood pressure before their index consultation. * Get their drug refilled automatically as well as have consultations deferred 16-18 weeks later, if their blood pressure is under optimal control. * Have consultations as scheduled, if their BP is suboptimal or any of the safety questions screen positive. Participants in control group will: * Have consultation with physicians every 16-18 weeks.

Conditions

Interventions

TypeNameDescription
DEVICETelemedicinea mobile app and telemedicine platform to confirm good blood pressure control and may save doctor face-to-face consultation
OTHERUsual careParticipants will be followed up as usual by face-to-face consultation with the doctors

Timeline

Start date
2024-10-01
Primary completion
2027-09-30
Completion
2027-09-30
First posted
2024-07-29
Last updated
2025-12-10

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06524180. Inclusion in this directory is not an endorsement.